Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALP-informed and BIS-guided fospropofol induction strategy in elderly patients
ChiCTR2600133595Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Yangzhou University
- Start
- Oct 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fospropofol disodium in intraoperative hypotension (IOH) and anesthesia-induced hypotension (2 arms), sponsored by The Affiliated Hospital of Yangzhou University. Primary endpoint: Incidence of hypotension in the induction phase. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
fospropofol disodium
03
Conditions
intraoperative hypotension (IOH)anesthesia-induced hypotension
Beyond the preview
Go deeper on ChiCTR2600133595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133595.